Publication | Open Access
Tranexamic acid for chronic subdural hematoma
28
Citations
15
References
2021
Year
TXA could be considered as primary medical treatment in patients with a cSDH and mild symptoms. The results of current randomized clinical trials must be awaited.
| Year | Citations | |
|---|---|---|
Page 1
Page 1